Malignant pleural mesothelioma: an update-Reference-Cited by-同舟云学术

Malignant pleural mesothelioma: an update

Published:2021-12-31 Issue: Volume: Page:e20210129
ISSN:1806-3756
Container-title:Jornal Brasileiro de Pneumologia
language:en
Short-container-title:J Bras Pneumol.

Author:

N. M. Hajj1,2 Glaucia¹,H. Cavarson1,2 Carolina¹,Lopes Pinto3 Clóvis Antônio²,Venturi1,4 Gabriela³,Navarro4 João R.⁴,C. Cordeiro de Lima2,5 Vladmir⁵

Affiliation:

1. 1. Instituto International de Pesquisa, A.C. Camargo Cancer Center, São Paulo (SP), Brasil. 2. Instituto Nacional de Oncogenômica e Inovação, São Paulo (SP), Brasil.

2. 3. Departamento de Patologia Anatômica, A.C. Camargo Cancer Center, São Paulo (SP), Brasil.

3. 1. Instituto International de Pesquisa, A.C. Camargo Cancer Center, São Paulo (SP), Brasil. 4. BP Mirante, São Paulo (SP), Brasil.

4. 4. BP Mirante, São Paulo (SP), Brasil.

5. 2. Instituto Nacional de Oncogenômica e Inovação, São Paulo (SP), Brasil. 5. Rede D’Or, São Paulo (SP), Brasil.

Abstract

Malignant mesotheliomas are rare types of cancers that affect the mesothelial surfaces, usually the pleura and peritoneum. They are associated with asbestos exposure, but due to a latency period of more than 30 years and difficult diagnosis, most cases are not detected until they reach advanced stages. Treatment options for this tumor type are very limited and survival ranges from 12 to 36 months. This review discusses the molecular physiopathology, current diagnosis, and latest therapeutic options for this disease.

Publisher

Sociedade Brasileira de Pneumologia e Tisiologia

Reference171 articles.

1. 1. Marinaccio A, Binazzi A, Marzio DD, Scarselli A, Verardo M, Mirabelli D, et al. Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register. Int J Cancer. 2012;130(9):2146-54. http://dx.doi.org/10.1002/ijc.26229. PMid:21647880.

2. 2. Grondin SC, Sugarbaker DJ. Malignant mesothelioma of the pleural space. Oncology. 1999;13(7):919-26. PMid:10442339.

3. 3. Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Les décés mondiaux par mésothéliome rapportés á l’Organisation mondiale de la Santé entre 1994 et 2008. Bull World Health Organ. 2011;89(10):716-24. http://dx.doi.org/10.2471/BLT.11.086678. PMid:22084509.

4. 4. Bridda A, Padoan I, Mencarelli R, Frego M. Peritoneal mesothelioma: a review. MedGenMed. 2007;9(2):32. PMid:17955087.

5. 5. Scherpereel A, Wallyn F, Albelda SM, Munck C. Novel therapies for malignant pleural mesothelioma. Lancet Oncol. 2018;19(3):e161-72. http://dx.doi.org/10.1016/S1470-2045(18)30100-1. PMid:29508763.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Status of Indian Cancer Record Keeping and Study of Mesothelioma Cases to Ascertain Asbestos Exposure in India;2023-12-19

2. Long Non-coding RNALINC00152RequiresEZH2to Promote Mesothelioma Cell Proliferation, Migration, and Invasion;Anticancer Research;2023-11-29

3. Updates in Management of Malignant Pleural Mesothelioma;Current Treatment Options in Oncology;2023-11-17

4. Co-existing pericardial and pleural malignant mesothelioma responding well to nedaplatin and pemetrexed: a case report;AME Case Reports;2023-10

5. Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma;Frontiers in Immunology;2023-03-17